Cerenome vs Icecure Medical
Cerenome is the larger business, with $5.2m of revenue in fiscal 2025 against $3.4m for Icecure Medical (1.5 times as much). Icecure Medical grew faster (2.7% against -10.5%). Cerenome kept more of each dollar of sales as profit: a net margin of -429.4% against -445.6%. Icecure Medical carries less debt relative to equity (0.1% against 18.8%).
| Latest fiscal year | CerenomeCNSY, 2025 | Icecure MedicalICCM, 2025 |
|---|---|---|
| Revenue | $5.2m | $3.4m |
| Revenue growth | -10.5% | 2.7% |
| Net income | −$22.4m | −$15.1m |
| Operating margin | -293.5% | -446.7% |
| Net margin | -429.4% | -445.6% |
| Return on equity | — | -188.8% |
| Free cash flow | −$20.8m | −$14.6m |
| Cash | $4.3m | $8.9m |
| Total debt | $750,000 | $13,000 |
| Debt to equity | 18.8% | 0.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 28 | — |
| Market value | $9.6m | $57.0m |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 1 buys, 0 sales | 0 buys, 0 sales |